• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于分析泮托拉唑起始原料中潜在遗传毒性杂质的液相色谱-串联质谱法的开发与验证

Development and Validation of LC-MS/MS for Analyzing Potential Genotoxic Impurities in Pantoprazole Starting Materials.

作者信息

Chen Yuyuan, Wu Song, Yang Qingyun

机构信息

Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.

出版信息

J Anal Methods Chem. 2020 Mar 9;2020:6597363. doi: 10.1155/2020/6597363. eCollection 2020.

DOI:10.1155/2020/6597363
PMID:32211210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7085375/
Abstract

Pantoprazole sodium (PPZS) is a selective proton pump inhibitor used in the prevention and treatment of gastric acid-related diseases. Six potentially genotoxic impurities (PGIs) are involved in 5-difluoromethoxy-2-mercapto-1H-benzimidazole (DMBZ), which is the starting material of PPZS. To date, no suitable method has yet been developed for PGI separation and quantification at the threshold of toxicological concern levels. In this study, a sensitive and reliable liquid chromatography-tandem mass spectrometry method was developed and validated for the quantitative analysis of six PGIs in DMBZ according to the guidelines of the International Council for Harmonization (ICH). The calibration curves showed good linearity within the studied range, and the correlation coefficient of fitting exceeded 0.998 for each impurity. The sensitivity of the proposed method was in the range of 0.6-10.0 ng/mL. Good recoveries were observed in the range of 94.32%-107.43% with RSD values below 6.5%. Quantitative analysis of impurities in substance batches of DMBZ showed the high efficiency of the developed method at a low level. Hence, the proposed method is practical and useful in the detection and qualification of PGIs in DMBZ and may be applied to ensure the safe use of PPZS in clinical treatment.

摘要

泮托拉唑钠(PPZS)是一种用于预防和治疗胃酸相关疾病的选择性质子泵抑制剂。5-二氟甲氧基-2-巯基-1H-苯并咪唑(DMBZ)是PPZS的起始原料,其中涉及六种潜在的基因毒性杂质(PGIs)。迄今为止,尚未开发出适用于在毒理学关注阈值水平下分离和定量PGIs的方法。在本研究中,根据国际协调理事会(ICH)的指导原则,开发并验证了一种灵敏可靠的液相色谱-串联质谱法,用于定量分析DMBZ中的六种PGIs。校准曲线在研究范围内显示出良好的线性,每种杂质的拟合相关系数均超过0.998。所提出方法的灵敏度在0.6-10.0 ng/mL范围内。回收率在94.32%-107.43%范围内,相对标准偏差值低于6.5%,结果良好。对DMBZ物质批次中的杂质进行定量分析表明,所开发的方法在低水平下具有高效性。因此,所提出的方法在检测和鉴定DMBZ中的PGIs方面具有实用性和有效性,可用于确保PPZS在临床治疗中的安全使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d8/7085375/f35ef306ae4a/JAMC2020-6597363.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d8/7085375/8af59ebcf8da/JAMC2020-6597363.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d8/7085375/83ff125911dd/JAMC2020-6597363.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d8/7085375/f35ef306ae4a/JAMC2020-6597363.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d8/7085375/8af59ebcf8da/JAMC2020-6597363.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d8/7085375/83ff125911dd/JAMC2020-6597363.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d8/7085375/f35ef306ae4a/JAMC2020-6597363.003.jpg

相似文献

1
Development and Validation of LC-MS/MS for Analyzing Potential Genotoxic Impurities in Pantoprazole Starting Materials.用于分析泮托拉唑起始原料中潜在遗传毒性杂质的液相色谱-串联质谱法的开发与验证
J Anal Methods Chem. 2020 Mar 9;2020:6597363. doi: 10.1155/2020/6597363. eCollection 2020.
2
Simultaneous and trace level quantification of two potential genotoxic impurities in valsartan drug substance using UPLC-MS/MS.采用 UPLC-MS/MS 同时定量检测缬沙坦药物中两种潜在遗传毒性杂质的痕量水平。
J Pharm Biomed Anal. 2022 Apr 1;212:114630. doi: 10.1016/j.jpba.2022.114630. Epub 2022 Feb 8.
3
A selective and sensitive UPLC-MS/MS approach for trace level quantification of four potential genotoxic impurities in zolmitriptan drug substance.一种用于痕量检测佐米曲坦药物中四种潜在遗传毒性杂质的选择性和灵敏的 UPLC-MS/MS 方法。
J Pharm Biomed Anal. 2013 Oct;84:84-9. doi: 10.1016/j.jpba.2013.05.047. Epub 2013 Jun 10.
4
Determination of five potential genotoxic impurities in dalfampridine using liquid chromatography.
J Pharm Biomed Anal. 2017 Jan 30;133:27-31. doi: 10.1016/j.jpba.2016.10.013.
5
Structural identification and characterization of potential impurities of pantoprazole sodium.泮托拉唑钠潜在杂质的结构鉴定与表征
J Pharm Biomed Anal. 2007 Oct 18;45(2):201-10. doi: 10.1016/j.jpba.2007.05.032. Epub 2007 Jun 2.
6
Development and Validation of a Sensitive GC-MS/MS Method for the Determination of Five Potential Genotoxic Impurities in Abiraterone Acetate.建立并验证了一种灵敏的 GC-MS/MS 方法,用于测定醋酸阿比特龙中五种潜在遗传毒性杂质的含量。
J Chromatogr Sci. 2022 Feb 16;60(2):105-110. doi: 10.1093/chromsci/bmab052.
7
Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.开发并验证一种用于快速同时测定达芦那韦原料药中六种工艺相关杂质的选择性、灵敏且具有稳定性指示能力的超高效液相色谱-串联质谱法。
J Pharm Biomed Anal. 2016 Sep 5;128:141-148. doi: 10.1016/j.jpba.2016.05.026. Epub 2016 May 18.
8
A simple, sensitive, and straightforward LC-MS approach for rapid analysis of three potential genotoxic impurities in rabeprazole formulations.一种简单、灵敏、直接的 LC-MS 方法,用于快速分析雷贝拉唑制剂中三种潜在遗传毒性杂质。
J Sep Sci. 2018 Nov;41(21):3966-3973. doi: 10.1002/jssc.201800626. Epub 2018 Sep 10.
9
Trace Level Quantification of the (-)2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluoro-3-butyn-2-ol Genotoxic Impurity in Efavirenz Drug Substance and Drug Product Using LC-MS/MS.使用液相色谱-串联质谱法对依法韦仑原料药和制剂中痕量水平的(-)2-(2-氨基-5-氯苯基)-4-环丙基-1,1,1-三氟-3-丁炔-2-醇遗传毒性杂质进行定量分析。
Sci Pharm. 2015 Oct 18;84(3):456-466. doi: 10.3390/scipharm84030456.
10
Quantitative Determination of Four Potential Genotoxic Impurities in the Active Pharmaceutical Ingredients in TSD-1 Using UPLC-MS/MS.采用 UPLC-MS/MS 定量测定 TSD-1 中活性药物成分中的四种潜在遗传毒性杂质。
Molecules. 2022 Jun 27;27(13):4129. doi: 10.3390/molecules27134129.

引用本文的文献

1
Identification and Determination of Impurities in a New Therapeutic Agent for Fatty Liver Disease.一种新型脂肪肝疾病治疗药物中杂质的鉴定与测定
J Anal Methods Chem. 2023 Aug 4;2023:3116223. doi: 10.1155/2023/3116223. eCollection 2023.

本文引用的文献

1
A simple, sensitive, and straightforward LC-MS approach for rapid analysis of three potential genotoxic impurities in rabeprazole formulations.一种简单、灵敏、直接的 LC-MS 方法,用于快速分析雷贝拉唑制剂中三种潜在遗传毒性杂质。
J Sep Sci. 2018 Nov;41(21):3966-3973. doi: 10.1002/jssc.201800626. Epub 2018 Sep 10.
2
Chemometrically assisted development and validation of LC-MS/MS method for the analysis of potential genotoxic impurities in meropenem active pharmaceutical ingredient.化学计量学辅助开发和验证用于分析美罗培南活性药物成分中潜在基因毒性杂质的液相色谱-串联质谱法。
J Pharm Biomed Anal. 2017 Oct 25;145:307-314. doi: 10.1016/j.jpba.2017.06.061. Epub 2017 Jun 29.
3
A simple, selective, and sensitive gas chromatography-mass spectrometry method for the analysis of five process-related impurities in atenolol bulk drug and capsule formulations.
一种简单、选择性强且灵敏的气相色谱-质谱联用方法,用于分析阿替洛尔原料药和胶囊制剂中 5 种工艺相关杂质。
J Sep Sci. 2017 Aug;40(15):3086-3093. doi: 10.1002/jssc.201700252. Epub 2017 Jun 28.
4
Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.开发并验证一种用于快速同时测定达芦那韦原料药中六种工艺相关杂质的选择性、灵敏且具有稳定性指示能力的超高效液相色谱-串联质谱法。
J Pharm Biomed Anal. 2016 Sep 5;128:141-148. doi: 10.1016/j.jpba.2016.05.026. Epub 2016 May 18.
5
Identification, control strategies, and analytical approaches for the determination of potential genotoxic impurities in pharmaceuticals: a comprehensive review.药物中潜在遗传毒性杂质的鉴定、控制策略及分析方法:全面综述
J Sep Sci. 2015 Mar;38(5):764-79. doi: 10.1002/jssc.201401143. Epub 2015 Feb 4.
6
Development and validation of a systematic UPLC-MS/MS method for simultaneous determination of three phenol impurities in ritonavir.用于同时测定利托那韦中三种酚类杂质的系统超高效液相色谱-串联质谱法的开发与验证
J Pharm Biomed Anal. 2014 Mar;90:127-33. doi: 10.1016/j.jpba.2013.11.029. Epub 2013 Dec 4.
7
Method development and validation study for quantitative determination of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride a genotoxic impurity in pantoprazole active pharmaceutical ingredient (API) by LC/MS/MS.建立并验证了 LC/MS/MS 法用于定量测定泮托拉唑原料药中基因毒性杂质 2-氯甲基-3,4-二甲氧基吡啶盐酸盐。
J Pharm Biomed Anal. 2012 Nov;70:592-7. doi: 10.1016/j.jpba.2012.05.031. Epub 2012 Jun 5.
8
Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective.药品中遗传毒性杂质的鉴定、控制和测定策略:制药行业视角。
J Pharm Biomed Anal. 2011 Jun 25;55(4):662-7. doi: 10.1016/j.jpba.2010.11.039. Epub 2010 Dec 3.
9
Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD).单剂量、多剂量和群体药代动力学研究潘妥拉唑在临床诊断为胃食管反流病(GERD)的新生儿和早产儿中的应用。
Eur J Clin Pharmacol. 2010 Jun;66(6):555-61. doi: 10.1007/s00228-010-0811-8. Epub 2010 Mar 20.
10
Recent advances in trace analysis of pharmaceutical genotoxic impurities.近年来药物遗传毒性杂质痕量分析的进展。
J Pharm Biomed Anal. 2010 Apr 6;51(5):999-1014. doi: 10.1016/j.jpba.2009.11.009. Epub 2009 Nov 13.